Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis

Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

(2016) Tamar F. Barlam et al.   CLINICAL INFECTIOUS DISEASES

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

(2016) Andre C. Kalil et al.   CLINICAL INFECTIOUS DISEASES

Is Procalcitonin-Guided Antimicrobial Use Cost-Effective in Adult Patients with Suspected Bacterial Infection and Sepsis?

(2015) Michelle Harrison et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis

(2015) Michelle M. A. Kip et al.   JOURNAL OF MEDICAL ECONOMICS

Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

(2012) S. J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database

(2012) Ennie L. Cano et al.   CLINICAL THERAPEUTICS

Prevention of vancomycin induced nephrotoxicity: a review of preclinical data

(2012) Sepideh Elyasi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Procalcitonin for reduced antibiotic exposure in the critical care setting: A systematic review and an economic evaluation*

(2011) Daren K. Heyland et al.   CRITICAL CARE MEDICINE

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

(2010) Lila Bouadma et al.   LANCET